Press Releases

Apr 10, 2017

PharmaCyte Biotech’s Cannabis Research Program Sees Significant Progress in University of Northern Colorado Presentations

Apr 3, 2017

PharmaCyte Biotech Appoints Dr. Mark Rabe Director of Cannabis Program Development

Mar 22, 2017

PharmaCyte Biotech Strengthens Protection of Cancer Therapy with Patent Filing

Mar 17, 2017

PharmaCyte Biotech CEO Addresses IND Submission Questions

Mar 13, 2017

PharmaCyte Biotech Names Dr. Leonard Makowka as Senior Strategic Advisor

Feb 23, 2017

First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals

Feb 21, 2017

PharmaCyte Biotech Discusses Patient Enrollment and TD2’s Role in Upcoming Clinical Trial

Feb 13, 2017

PharmaCyte Biotech Moves Closer to Filing IND with Naming of Comparator Arm for Upcoming Clinical Trial and Discusses Pivotal Trial Opportunity

Feb 8, 2017

PharmaCyte Biotech Releases Shareholder Call and Complete Q&A Playback Information

Feb 2, 2017

PharmaCyte Biotech Provides Update for February 7th Shareholder Call